438 A phase 1 trial of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, alone and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck... by Michael Gibson, Ammar Sukari, Julie Bauman, Tanguy Seiwert, Barbara Burtness, Sara Pai, Cristina Rodriguez, Bonnie Glisson, Kenneth Pienta, Francis Worden, Lara Dunn, Douglas Adkins, Christine Chung, A Dimitrios Colevas, Lori Wirth, Nabil Saba, Laura Agensky, Matteo Levisetti, Reena Lynam, Steven Margossian, Raymond Moniz, Steve Quayle